Tabula Rasa Healthcare Inc. (NASDAQ:TRHC) insider Orsula V. Knowlton sold 8,000 shares of Tabula Rasa Healthcare stock in a transaction on Wednesday, October 18th. The shares were sold at an average price of $26.68, for a total value of $213,440.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.
Shares of Tabula Rasa Healthcare Inc. (NASDAQ TRHC) traded up 0.31% on Thursday, hitting $26.26. The stock had a trading volume of 66,412 shares. The stock has a 50 day moving average of $26.13 and a 200 day moving average of $26.13. The firm’s market cap is $453.93 million. Tabula Rasa Healthcare Inc. has a 12-month low of $10.39 and a 12-month high of $28.53.
Tabula Rasa Healthcare (NASDAQ:TRHC) last posted its quarterly earnings results on Monday, August 7th. The company reported $0.06 earnings per share for the quarter, meeting the Zacks’ consensus estimate of $0.06. Tabula Rasa Healthcare had a negative return on equity of 9.58% and a negative net margin of 10.27%. The company had revenue of $29.70 million for the quarter, compared to analysts’ expectations of $27.84 million. The firm’s quarterly revenue was up 32.6% on a year-over-year basis. Equities analysts predict that Tabula Rasa Healthcare Inc. will post $0.39 earnings per share for the current fiscal year.
ILLEGAL ACTIVITY NOTICE: “Orsula V. Knowlton Sells 8,000 Shares of Tabula Rasa Healthcare Inc. (TRHC) Stock” was reported by Transcript Daily and is the sole property of of Transcript Daily. If you are accessing this piece on another domain, it was illegally copied and reposted in violation of United States and international copyright law. The original version of this piece can be viewed at https://transcriptdaily.com/2017/10/19/orsula-v-knowlton-sells-8000-shares-of-tabula-rasa-healthcare-inc-trhc-stock.html.
Institutional investors have recently bought and sold shares of the business. TIAA CREF Investment Management LLC raised its stake in Tabula Rasa Healthcare by 108.5% in the first quarter. TIAA CREF Investment Management LLC now owns 8,131 shares of the company’s stock valued at $110,000 after buying an additional 4,232 shares in the last quarter. New York State Common Retirement Fund raised its stake in Tabula Rasa Healthcare by 257.0% in the second quarter. New York State Common Retirement Fund now owns 10,000 shares of the company’s stock valued at $151,000 after buying an additional 7,199 shares in the last quarter. Bank of New York Mellon Corp acquired a new stake in Tabula Rasa Healthcare in the first quarter valued at $178,000. Cadence Capital Management LLC acquired a new stake in Tabula Rasa Healthcare in the second quarter valued at $210,000. Finally, Teachers Advisors LLC raised its stake in Tabula Rasa Healthcare by 203.5% in the second quarter. Teachers Advisors LLC now owns 16,500 shares of the company’s stock valued at $248,000 after buying an additional 11,063 shares in the last quarter. Institutional investors own 28.85% of the company’s stock.
A number of research analysts have recently issued reports on the company. Chardan Capital assumed coverage on Tabula Rasa Healthcare in a report on Monday, July 10th. They issued a “buy” rating and a $19.50 price target on the stock. Wells Fargo & Company downgraded Tabula Rasa Healthcare from an “outperform” rating to a “market perform” rating and lifted their price target for the company from $17.00 to $21.00 in a report on Thursday, September 7th. Zacks Investment Research upgraded Tabula Rasa Healthcare from a “hold” rating to a “strong-buy” rating and set a $31.00 price target on the stock in a report on Wednesday, October 11th. Robert W. Baird reiterated an “outperform” rating and issued a $30.00 price target (up from $22.00) on shares of Tabula Rasa Healthcare in a report on Tuesday. Finally, Piper Jaffray Companies reiterated an “overweight” rating and issued a $20.00 price target (up from $19.00) on shares of Tabula Rasa Healthcare in a report on Wednesday, August 9th. Two equities research analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the company’s stock. Tabula Rasa Healthcare has an average rating of “Buy” and an average price target of $25.57.
Tabula Rasa Healthcare Company Profile
Tabula Rasa HealthCare, Inc (Tabula Rasa), formerly CareKinesis, Inc, is a provider of patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations and manage risk. The Company delivers its solutions through a suite of technology-enabled products and services for medication risk management, which includes bundled prescription fulfillment and adherence packaging services for client populations with complex prescription needs.
Receive News & Ratings for Tabula Rasa Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa Healthcare Inc. and related companies with MarketBeat.com's FREE daily email newsletter.